In this interview with the Vice President of Global Development at Amgen we take a more in-depth look at the trastuzumab data, an oncology biosimilar medicine.
In this interview discover further details of the JAVELIN Merkel 200 that led to the approval of the first immunotherapy treatment indicated in the EU and the first US FDA-approved systemic therapy for merkel cell carcinoma.
Could you give us a brief overview of the SCORES trial? The SCORES trial was a two-part study; the first…
In this podcast discover details of the TONIC trial which has yielded promising response rates in patients with metastatic triple-negative breast cancer treated with nivolumab after induction treatment.
Listen to this podcast to discover more about the UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain).
In this video Chris Lewis describes the best and worst aspects of his care and explains how he would like care for cancer patients improve over the coming years.
What is the potential clinical significance of the results of the FLAURA trial presented at ESMO? Find out in our exclusive interview.
Chris was diagnosed with lymphoma in 2007, as part of his treatment he received a stem cell transplant – in this video you can discover what it is like to undergo a stem cell transplant and find out how it is performed.
Chris Lewis (Patient Advocate and Founder of Chris’s Cancer Community) discusses the treatment he underwent following his diagnosis with lymphoma in…
Listen to this podcast to discover more about CheckMate-153 study, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain).